Comparison Chart Alterity Therapeutics Limited Nasdaq

Equities

Market Closed - Nasdaq Other stock markets 01:30:00 15/06/2024 am IST			5-day change	1st Jan Change
1.86 ^USD	-1.59%		+0.54%	-25.30%

08/05	Alterity Therapeutics Phase 2 Data Monitoring Committee Recommends Continuing Clinical Trial as Planned After Third Review	CI
08/05	Alterity Therapeutics on Track to Complete Phase Two Trial of Lead Drug Candidate in November	MT

Total Return

"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

		Sector	Change	5d. change	1st Jan change	1-year change	5-years change	Capi.	ST	MT	LT
	ALTERITY THERAPEUTICS LIMITED	Other Biotechnology & Medical Research	-1.59%	+0.54%	-25.30%	-35.86%	-86.42%	1.73Cr	-	-	-